Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/24453
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNguyen, Vinh A-
dc.contributor.authorRiddell, Nina-
dc.contributor.authorCrewther, Sheila G-
dc.contributor.authorFaou, Pierre-
dc.contributor.authorRajapaksha, Harinda-
dc.contributor.authorHowells, David W-
dc.contributor.authorHankey, Graeme J-
dc.contributor.authorWijeratne, Tissa-
dc.contributor.authorMa, Henry-
dc.contributor.authorDavis, Stephen-
dc.contributor.authorDonnan, Geoffrey A-
dc.contributor.authorCarey, Leeanne M-
dc.date2020-07-28-
dc.date.accessioned2020-09-28T20:38:27Z-
dc.date.available2020-09-28T20:38:27Z-
dc.date.issued2020-07-28-
dc.identifier.citationFrontiers in Neurology 2020; 11: 692en
dc.identifier.issn1664-2295
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/24453-
dc.description.abstractCurrently the longitudinal proteomic profile of post-ischemic stroke recovery is relatively unknown with few well-accepted biomarkers or understanding of the biological systems that underpin recovery. We aimed to characterize plasma derived biological pathways associated with recovery during the first year post event using a discovery proteomics workflow coupled with a topological pathway systems biology approach. Blood samples (n = 180, ethylenediaminetetraacetic acid plasma) were collected from a subgroup of 60 first episode stroke survivors from the Australian START study at 3 timepoints: 3-7 days (T1), 3-months (T2) and 12-months (T3) post-stroke. Samples were analyzed by liquid chromatography mass spectrometry using label-free quantification (data available at ProteomeXchange with identifier PXD015006). Differential expression analysis revealed that 29 proteins between T1 and T2, and 33 proteins between T1 and T3 were significantly different, with 18 proteins commonly differentially expressed across the two time periods. Pathway analysis was conducted using Gene Graph Enrichment Analysis on both the Kyoto Encyclopedia of Genes and Genomes and Reactome databases. Pathway analysis revealed that the significantly differentiated proteins between T1 and T2 were consistently found to belong to the complement pathway. Further correlational analyses utilized to examine the changes in regulatory effects of proteins over time identified significant inhibitory regulation of clusterin on complement component 9. Longitudinal post-stroke blood proteomics profiles suggest that the alternative pathway of complement activation remains in a state of higher activation from 3-7 days to 3 months post-stroke, while simultaneously being regulated by clusterin and vitronectin. These findings also suggest that post-stroke induced sterile inflammation and immunosuppression could inhibit recovery within the 3-month window post-stroke.en
dc.language.isoeng
dc.subjectbioinformaticsen
dc.subjectcomplement systemen
dc.subjectimmune systemen
dc.subjectlongitudinalen
dc.subjectpathway analysisen
dc.subjectproteomicsen
dc.subjectStrokeen
dc.subjectsystems biologyen
dc.titleLongitudinal Stroke Recovery Associated With Dysregulation of Complement System-A Proteomics Pathway Analysis.en
dc.typeJournal Articleen
dc.identifier.journaltitleFrontiers in Neurologyen
dc.identifier.affiliationDepartment of Psychology and Counselling, La Trobe University, Bundoora, VIC, Australiaen
dc.identifier.affiliationDepartment of Medicine, The University of Melbourne, Sunshine, VIC, Australiaen
dc.identifier.affiliationDepartment of Occupational Therapy, La Trobe University, Bundoora, VIC, Australiaen
dc.identifier.affiliationDepartment of Neurology, Royal Melbourne Hospital, Parkville, VIC, Australiaen
dc.identifier.affiliationDepartment of Biochemistry and Genetics, La Trobe University, Bundoora, VIC, Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen
dc.identifier.affiliationMonash Health, Neurology and Stroke, Clayton, VIC, Australiaen
dc.identifier.affiliationClinical Research, Harry Perkins Institute of Medical Research, Perth, WA, Australiaen
dc.identifier.affiliationFaculty of Health and Medical Sciences, Internal Medicine, University of Western Australia, Perth, WA, Australiaen
dc.identifier.affiliationMedical Sciences Precinct, University of Tasmania, Hobart, TAS, Australiaen
dc.identifier.affiliationWestern Health, Department of Neurology, Sunshine, VIC, Australiaen
dc.identifier.doi10.3389/fneur.2020.00692en
dc.type.contentTexten
dc.identifier.pubmedid32849183
local.name.researcherCarey, Leeanne M
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

56
checked on Nov 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.